Miaoli, Taiwan

Jia-ni Tian

This inventor holds 1 USPTO granted patent. Top assignees: Development Center for Biotechnology, National Health Research Institutes. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jia-ni Tian. Retrieved from https://idiyas.com/inventor/jia-ni-tian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jia-ni Tian

Introduction

Jia-ni Tian is a notable inventor based in Miaoli, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on addressing diseases related to neurotensin receptor 1 (NTSR1) activity.

Latest Patents

Jia-ni Tian holds a patent for "Humanized anti-human neurotensin receptor 1 antibodies and their uses." This patent describes a humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. It also outlines methods for treating, prophylactic treating, and preventing diseases and disorders caused by or related to NTSR1 activity and signaling. Additionally, the patent includes a method or kit for detecting NTSR1 in a sample. He has 1 patent to his name.

Career Highlights

Throughout his career, Jia-ni Tian has worked with prominent organizations such as the Development Center for Biotechnology and the National Health Research Institutes. His experience in these institutions has allowed him to advance his research and contribute to the field of biotechnology.

Collaborations

Jia-ni Tian has collaborated with notable colleagues, including Ren-Huang Wu and Chao-Yang Huang. Their joint efforts have furthered the understanding and application of NTSR1-related therapies.

Conclusion

Jia-ni Tian's innovative work in the field of biotechnology, particularly with NTSR1 antibodies, showcases his dedication to advancing medical science. His contributions are significant in the ongoing fight against diseases related to neurotensin receptor activity.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…